Katherine King, - Pharmacist in Willmar, MN

Katherine King, is a Pharmacist based in Willmar, Minnesota. Katherine King is licensed to practice in Minnesota (license number 120127) and her current practice location is 700 19th Ave Se, Willmar, Minnesota. She can be reached at her office (for appointments etc.) via phone at (320) 231-3313.

NPI number for Katherine King is 1063968543 and her current mailing address is 700 19th Ave Se, Willmar, Minnesota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1063968543.

Contact Information

Katherine King,
700 19th Ave Se,
Willmar, MN 56201-5499
(320) 231-3313
Not Available

Healthcare Provider's Profile

Full NameKatherine King
GenderFemale
SpecialityPharmacist
Location700 19th Ave Se, Willmar, Minnesota
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1063968543
  • Provider Enumeration Date: 08/25/2016
  • Last Update Date: 08/25/2016

Medical Identifiers

Medical identifiers for Katherine King such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063968543NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 120127 (Minnesota)Primary
183500000XPharmacist 5789 (South Dakota)Secondary
183500000XPharmacist 25668 (North Carolina)Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Katherine King is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Katherine King,
700 19th Ave Se,
Willmar, MN 56201-5499

Ph: () -
Katherine King,
700 19th Ave Se,
Willmar, MN 56201-5499

Ph: (320) 231-3313

News Archive

Phase 3 study of D-tagatose in Type 2 diabetes shows significant reduction in HbA1c levels

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes

Questions circle over health reform's effect on rising costs

"The White House has started to aggressively push back against a growing narrative that pending health reform legislation doesn't do enough to control spiraling health costs," Politico reports. Peter Orszag said reporters who go "on buzz and sort of loose talk," instead of doing "the hard work," were partly to blame for the pending narrative.

Researchers explain evolution of lifespan

Stanford scientists show in a forthcoming paper that traditional mating patterns make men the key to explaining away the "wall of death," an enduring puzzle in the study of human longevity.

Zika pandemic remains formidable challenge to medicine and public health, say experts

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 80 countries, infected millions of people, and left many babies with birth defects (collectively called congenital Zika syndrome).

Opinion: IVAWA marks 'first step' towards making women central focus of U.S. foreign policy

In a Politico opinion piece, Sen. John Kerry (D-Mass.) and Rep. Bill Delahunt (D-Mass.), lead sponsors of the International Violence Against Women Act (IVAWA), together with Larry Cox and Kerry Kennedy of Amnesty International USA, reflect on the significance of the legislation introduced in the House and Senate on Thursday.

Read more News

› Verified 4 days ago


Pharmacist in Willmar, MN

Michelle Bjerke,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2300 1st St S, Willmar, MN 56201
Phone: 320-235-1930    
Todd Parker,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 2300 1st St S, Willmar, MN 56201
Phone: 320-235-1930    
Allison Krause,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 700 19th Ave Se, Willmar, MN 56201
Phone: 320-231-3313    
Dr. Amanda Marie Thompson, PHARMD BCPS
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 301 Becker Ave Sw, Willmar, MN 56201
Phone: 320-231-4914    Fax: 320-231-4850
Gunjan Shah,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201
Phone: 585-278-6558    
Dennis John Schaefbauer, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201
Phone: 320-214-6975    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.